How do you think Shah Rukh Khan maintains his full head of hair at 60? 12/9/2025
Shah Rukh Khan's hair at 60 is attributed to genetics, with speculation about using finasteride, minoxidil, or hair transplants. Some believe it's due to good genes, while others think he might use treatments or have had hair procedures.
View this post in the Community →
Similar Community Posts Join
6 / 6 resultscommunity Minoxidil aint shit, genetics are dumb, i dont want to be bald
Minoxidil alone is not effective for significant hair regrowth; combining it with finasteride or dutasteride is necessary. Additional treatments like hair transplants, microneedling, or oral medications are recommended for better results.
community Anyone who started balding in their early 20s and managed to salvage their hair with fin/dut & min?
Finasteride, minoxidil, and sometimes dutasteride were used for hair loss with varying success. Some experienced side effects, while others maintained or regrew hair, considering hair transplants as a future option.
community Why are you so obsessed with celebrities using finasteride or dutasteride?
Celebrities using hair loss treatments like finasteride, minoxidil, and hair transplants is common and helps normalize these practices for the public. Many believe acknowledging this reduces stigma and provides reassurance that these treatments are effective and widely used.
community 2020 updated guide for "I'm losing my hair, what do I do?". I've been taking Propecia for 12 years, and you can AMA.
Hair loss treatments discussed include Propecia, Rogaine, Nizoral shampoo, and dermarolling. Users shared experiences and results, with some noticing improvements in hair growth and maintenance.
community You Long term fin users, how are y’all going 10 or 15 years down the road? Does it actually work for most people?
Long-term finasteride users report maintaining hair and experiencing regrowth, with some using it for over 20 years. Combining finasteride with minoxidil or hair transplants can improve results.
community I [19m] have been on finastride for almost 2 years and I am still receding
A 19-year-old male has been using finasteride and minoxidil for nearly two years but continues to experience hairline recession. He is considering switching to dutasteride and exploring options like hair systems and potential future hair transplants.
Related Research
6 / 6 resultsresearch Androgenetic Alopecia in Men: An Update On Genetics
In this review, an association was reported between early-onset androgenetic alopecia and several health conditions like obesity and cardiovascular disease, with genetic and therapeutic research ongoing to improve treatment.
research Epidemiology, Genetics & Risk factors in Alopecia Androgenetics
This review explores the complex pathophysiology of androgenetic alopecia, highlighting genetic factors, androgen metabolism, and emerging therapies such as platelet-rich plasma and low-level laser therapy, but notes that no ultimate cure exists and treatments focus on slowing progression and promoting hair growth.
research Clinical Perspectives on Alopecia: From Hair Follicle Biology to Advanced Therapies
This review highlights the various causes and treatment options for alopecia, noting that while non-scarring types often see successful hair regrowth, scarring forms require early intervention to manage inflammatory destruction of hair follicles.
research Breaking bald: Unraveling the mysteries of hair loss and modern treatments
This review explored the causes and treatment options for hair loss, highlighting current therapies like minoxidil and hair transplants, while also emphasizing the need for new approaches such as gene therapies and advanced delivery methods for improved outcomes.
research Epidemiology, Genetics & Risk factors in Alopecia Androgenetics
This review discusses the pathophysiology, molecular events, and therapeutic options for androgenetic alopecia, but reports no new clinical findings.
research ANDROGENETIC ALOPECIA
This review discusses advancements in understanding the genetic and stem cell involvement in androgenetic alopecia, evaluates current treatments, and emphasizes the need for evidence-based guidelines but presents no new clinical results.